Activation of endogenous protein phosphatase 1 enhances the calcium sensitivity of the ryanodine receptor type 2 in murine ventricular cardiomyocytes

被引:14
|
作者
Potenza, Duilio Michele [1 ]
Janicek, Radoslav [1 ]
Fernandez-Tenorio, Miguel [1 ]
Niggli, Ernst [1 ]
机构
[1] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2020年 / 598卷 / 06期
基金
瑞士国家科学基金会;
关键词
Ca2+-induced Ca2+ release; cardiac muscle; de-phosphorylation; excitation-contraction coupling; protein phosphatase; ryanodine receptor 2; BETA-ADRENERGIC STIMULATION; HEART-FAILURE; CA2+ RELEASE; PKA PHOSPHORYLATION; RYR2; PHOSPHORYLATION; GENETIC ABLATION; OKADAIC ACID; SERINE; 2808; KINASE-II; HYPERPHOSPHORYLATION;
D O I
10.1113/JP278951
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Key points Increased protein phosphatase 1 (PP-1) activity has been found in end stage human heart failure. Although PP-1 has been extensively studied, a detailed understanding of its role in the excitation-contraction coupling mechanism, in normal and diseased hearts, remains elusive. The present study investigates the functional effect of the PP-1 activity on local Ca2+ release events in ventricular cardiomyocytes, by using an activating peptide (PDP3) for the stimulation of the endogenous PP-1 protein. We report that acute de-phosphorylation may increase the sensitivity of RyR2 channels to Ca2+ in situ, and that the RyR2-serine2808 phosphorylation site may mediate such a process. Our approach unmasks the functional importance of PP-1 in the regulation of RyR2 activity, suggesting a potential role in the generation of a pathophysiological sarcoplasmic reticulum Ca2+ leak in the diseased heart. Changes in cardiac ryanodine receptor (RyR2) phosphorylation are considered to be important regulatory and disease related post-translational protein modifications. The extent of RyR2 phosphorylation is mainly determined by the balance of the activities of protein kinases and phosphatases, respectively. Increased protein phosphatase-1 (PP-1) activity has been observed in heart failure, although the regulatory role of this enzyme on intracellular Ca2+ handling remains poorly understood. To determine the physiological and pathophysiological significance of increased PP-1 activity, we investigated how the PP-1 catalytic subunit (PP-1c) alters Ca2+ sparks in permeabilized cardiomyocytes and we also applied a PP-1-disrupting peptide (PDP3) to specifically activate endogenous PP-1, including the one anchored on the RyR2 macromolecular complex. We compared wild-type and transgenic mice in which the usually highly phosphorylated site RyR2-S2808 has been ablated to investigate its involvement in RyR2 modulation (S2808A(+/+)). In wild-type myocytes, PP-1 increased Ca2+ spark frequency by two-fold, followed by depletion of the sarcoplasmic reticulum Ca2+ store. Similarly, PDP3 transiently increased spark frequency and decreased sarcoplasmic reticulum Ca2+ load. RyR2 Ca2+ sensitivity, which was assessed by Ca2+ spark recovery analysis, was increased in the presence of PDP3 compared to a negative control peptide. S2808A(+/+) cardiomyocytes did not respond to both PP-1c and PDP3 treatment. Our results suggest an increased Ca2+ sensitivity of RyR2 upon de-phosphorylation by PP-1. Furthermore, we have confirmed the S2808 site as a target for PP-1 and as a potential link between RyR2s modulation and the cellular response.
引用
收藏
页码:1131 / 1150
页数:20
相关论文
共 50 条
  • [31] Antiadrenergic effects of adenosine A1 receptor-mediated protein phosphatase 2a activation in the heart
    Liu, QH
    Hofmann, PA
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (04): : H1314 - H1321
  • [32] Regulation of dopamine D1-receptor activation in vivo by protein phosphatase 2B (calcineurin)
    Adlersberg, M
    Hsiung, SC
    Glickstein, SB
    Liu, KP
    Tamir, H
    Schmauss, C
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (04) : 865 - 873
  • [33] Malignant Hyperthermia Associated Mutations in S2-S3 Loop of Type 1 Ryanodine Receptor Calcium Channel Alter Calcium Dependent Inactivation
    Gomez, Angela C.
    Holford, Timothy
    Yamaguchi, Naohiro
    BIOPHYSICAL JOURNAL, 2014, 106 (02) : 110A - 110A
  • [34] Activation of the ATP.Mg-dependent type 1 protein phosphatase by the Fe2+/ascorbate system
    Yu, JS
    Chan, WH
    Yang, SD
    JOURNAL OF PROTEIN CHEMISTRY, 1996, 15 (05): : 455 - 460
  • [35] Cardiac Hypertrophy Associated with Impaired Regulation of Type2 Ryanodine Receptor Calcium Channel by Calmodulin and S100A1
    Yamaguchi, Naohiro
    Chakraborty, Asima
    Huang, Tai-Qin
    Xu, Le
    Gomez, Angela C.
    Pasek, Daniel A.
    Meissner, Gerhard
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 442A - 442A
  • [36] Extracellular S100A1 protein inhibits apoptosis in ventricular cardiomyocytes via activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2)
    Most, P
    Boerries, M
    Eicher, C
    Schweda, C
    Ehlermann, P
    Pleger, ST
    Loeffler, E
    Koch, WJ
    Katus, HA
    Schoenenberger, CA
    Remppis, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (48) : 48404 - 48412
  • [37] Mutant mice lacking ryanodine receptor type 3 exhibit deficits of contextual fear conditioning and activation of calcium/calmodulin-dependent protein kinase II in the hippocampus
    Kouzu, Y
    Moriya, T
    Takeshima, H
    Yoshioka, T
    Shibata, S
    MOLECULAR BRAIN RESEARCH, 2000, 76 (01): : 142 - 150
  • [38] Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer
    Karlsson, Elin
    Veenstra, Cynthia
    Emin, Shad
    Dutta, Chhanda
    Perez-Tenorio, Gizeh
    Nordenskjold, Bo
    Fornander, Tommy
    Stal, Olle
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (01) : 31 - 40
  • [39] S100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytes
    Reppel, M
    Sasse, P
    Piekorz, R
    Tang, M
    Roell, W
    Duan, YQ
    Kletke, A
    Hescheler, J
    Nurnberg, B
    Fleischmann, BK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (43) : 36019 - 36028
  • [40] Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer
    Elin Karlsson
    Cynthia Veenstra
    Shad Emin
    Chhanda Dutta
    Gizeh Pérez-Tenorio
    Bo Nordenskjöld
    Tommy Fornander
    Olle Stål
    Breast Cancer Research and Treatment, 2015, 153 : 31 - 40